Received: from EUR03-DBA-obe.outbound.protection.outlook.com (2a01:111:f403:260d::72f) by AM3PEPF0000A794.mail.protection.outlook.com (2603:10a6:20f:fff4:0:7:0:b) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.8655.12 via Frontend Transport; Wed, 16 Apr 2025 13:45:13 +0000 Received: from AM3PEPF0000A794.eurprd04.prod.outlook.com (2603:10a6:209:8f:cafe::c4) by AM6P194CA0104.outlook.office365.com (2603:10a6:209:8f::45) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.8632.35 via Frontend Transport; Wed, 16 Apr 2025 13:45:13 +0000 Received: from AS1PR02MB8186.eurprd02.prod.outlook.com ([fe80::38aa:5673:c07a:d984]) by AS1PR02MB8186.eurprd02.prod.outlook.com ([fe80::38aa:5673:c07a:d984%3]) with mapi id 15.20.8632.030; Wed, 16 Apr 2025 13:45:11 +0000 Received: from AS1PR02MB8186.eurprd02.prod.outlook.com (2603:10a6:20b:475::6) by DU5PR02MB10568.eurprd02.prod.outlook.com (2603:10a6:10:527::11) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.8632.33; Wed, 16 Apr 2025 13:45:11 +0000 Received: from AM6P194CA0104.EURP194.PROD.OUTLOOK.COM (2603:10a6:209:8f::45) by AS2PR02MB9980.eurprd02.prod.outlook.com (2603:10a6:20b:604::10) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.8632.30; Wed, 16 Apr 2025 13:45:14 +0000 Received: from AS2PR02MB9980.eurprd02.prod.outlook.com (2603:10a6:20b:604::10) by DU0PR02MB8856.eurprd02.prod.outlook.com with HTTPS; Wed, 16 Apr 2025 13:45:18 +0000 From: "Avaldused" To: "Peeter Padrik" References: In-Reply-To: Subject: =?utf-8?Q?RE:_Taotlus_geeniandmete_v=C3=A4ljast?= =?utf-8?Q?amiseks?= Date: Wed, 16 Apr 2025 16:45:11 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0034_01DBCA31.E3D69220" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQHbl+xQrp7K0xjjrk614KNZngBJTLOmeyOg Authentication-Results: spf=pass (sender IP is 2a01:111:f403:260d::72f) smtp.mailfrom=geenidoonor.ee; dkim=pass (signature was verified) header.d=geenidoonor.ee;dmarc=pass action=none header.from=geenidoonor.ee;compauth=pass reason=100 X-MS-Has-Attach: X-MS-TNEF-Correlator: x-ms-traffictypediagnostic: AS1PR02MB8186:EE_|DU5PR02MB10568:EE_|AM3PEPF0000A794:EE_|AS2PR02MB9980:EE_|DU0PR02MB8856:EE_ X-MS-Office365-Filtering-Correlation-Id: ef0efcba-5a24-4085-8cb3-08dd7cecea01 x-ld-processed: 6d356317-0d04-4abc-b6b6-8c9773885bb0,ExtAddr x-ms-exchange-senderadcheck: 1 x-ms-exchange-antispam-relay: 0 X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|1800799024|10070799003|376014|366016|38070700018|7053199007|13003099007|8096899003; X-Microsoft-Antispam-Message-Info-Original: =?us-ascii?Q?HUfCD4Pb85q8n3qiGVO4wUKHhVxas5P+TvbmUlmROj7oKcLdZnbs6y64O/+F?= =?us-ascii?Q?wSxe7kPywe+1Lodr0lxwzHDshUTXafbzVYkCoka/+mqB02sD7tKGP08DqCUf?= =?us-ascii?Q?XaGjj+C14bAEz4dX9fnn5yKEW5tpNKe6Dy/aHV0oBjEYJQHvM6pwtH9NPHoN?= =?us-ascii?Q?Wewe/Zd7tvRvIaWDK3pF5sxteSrQrwbsDkmqZRhPS6Bs4VA0nZVlb2M2xml/?= =?us-ascii?Q?UKDR4WqrtAQqkeEQWiV5TPjikMy9l1VtJArS89oc5LQ34jPNMBdMqRWltcaf?= =?us-ascii?Q?Nm6aJOUO0m5KBJw4vLRjZsPIFNbtwRMcBOCovdCHG/V3rYYrC0mqbfR9RNKQ?= =?us-ascii?Q?+wUFno3FA3ImzsnDxq4LblcktCKggtJGXiMs8COy3PVGcXhqD90DewSEDBep?= =?us-ascii?Q?H3QUgBwdZi7rK9pIDkTOgVpXGRSblODN77c/OJt2NlF0UOOoJavQV7IRzcY2?= =?us-ascii?Q?6FGi+yZhUwhLHIqU2SWmKiitOXxciKCHuH+unmthKcH70onOtjJFdKlYqIxj?= =?us-ascii?Q?YPIMRE72i00kZONr5wOl+CrtoRrUeVQOEPhMU9LtlnSoLse6VTy2rT69hUqW?= =?us-ascii?Q?TV+jeGwKduI+0CAiQDB+I2Lg8OOFJFeXho5rWw8U9vAjun1bpxw/UAfWl0Vw?= =?us-ascii?Q?hZqMxkXnj7p/0RrBxlHNzHlfsbdSqFwxdHAX/jBu3H7iwwz3hmB74kcUqLzE?= =?us-ascii?Q?8jluVU3hiEpyjzJut8lf1cM8Z4DfapHIo+Pecj1QHvB30jp4GxR ZAC17D+TJ?= =?us-ascii?Q?VrMvFh4WI5sfdZ0vM//4RIIqBAlbCZxnLeoo7cEe2gwekkzEwWusHgm5Bgah?= =?us-ascii?Q?6JL9MqNcx/h1MKLfkGKMYE1Eqf7TIpyn/mpCQOUtosohrgs6NROQ1vN5yrFH?= =?us-ascii?Q?Mu74zIt4gF7EtVygOkrBJEWisqmqKbwmQUaDohCO4kzvc81J19GpBBO+hCtK?= =?us-ascii?Q?mw6ehQfiluy6CzRT9bajX1bJvQDQ1SZfoJaP7riN1tTmLALD7cmyNtuD8boh?= =?us-ascii?Q?mvR5v6EInE8p1a++M2gCAgPCyVD01BqwVnnHjjiC5IpixMHFAslr2v20DGwY?= =?us-ascii?Q?vlbQA+eabaRXtBZfzku7FPovbHcDhUc0cntM3Xgvk86+v0G+Qw9IEbk7ydEX?= =?us-ascii?Q?C4XEDAfHuutwrsaL9Vb0VCdEtuolbdYPDyEiGhDjqdpPo8Nxx8ZZAWYCagbi?= =?us-ascii?Q?KlNnN/eXew65pV/EsHdrDBcDlMaxMxjYOp1wmLeqekkQ4lq46Hvw4sVoNPKo?= =?us-ascii?Q?fdCH3dGA8KpW4Og1WZiOIstneCb0YbrikfzhrH9FqAyIaFyc3xeig7mOmrnh?= =?us-ascii?Q?/IP+gQj6UOVdqQAWzwNvyRBjVvch2OW9TA86Rg36gWS3lOdqoRJ39I7uQ3lG?= =?us-ascii?Q?J6xDopEgk8ooolJKVNSG5Ny7NiVgLp9New/wzhw1lbgB1ex7Y6rGZ38FV+wE?= =?us-ascii?Q?8NonpmxpR8g=3D?= X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:AS1PR02MB8186.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(1800799024)(10070799003)(376014)(366016)(38070700018)(7053199007)(13003099007)(8096899003);DIR:OUT;SFP:1102; X-MS-Exchange-Transport-CrossTenantHeadersStamped: AS2PR02MB9980 X-MS-Exchange-Transport-CrossTenantHeadersStamped: DU5PR02MB10568 X-MS-Exchange-Organization-ExpirationStartTime: 16 Apr 2025 13:45:13.6574 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: ef0efcba-5a24-4085-8cb3-08dd7cecea01 X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 02f4eddd-f9a7-41fd-ab0f-050b4ecc86e8:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-Exchange-Transport-CrossTenantHeadersStripped: AM3PEPF0000A794.eurprd04.prod.outlook.com X-MS-PublicTrafficType: Email X-MS-Exchange-Organization-AuthSource: AM3PEPF0000A794.eurprd04.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id-Prvs: fa9da267-4d71-401f-bc1a-08dd7cece8af X-MS-Exchange-AtpMessageProperties: SA|SL X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|35042699022|7053199007|13003099007|8096899003; X-Forefront-Antispam-Report: CIP:2a01:111:f403:260d::72f;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:EUR03-DBA-obe.outbound.protection.outlook.com;PTR:mail-dbaeur03on2072f.outbound.protection.outlook.com;CAT:NONE;SFS:(13230040)(35042699022)(7053199007)(13003099007)(8096899003);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 16 Apr 2025 13:45:13.5480 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: ef0efcba-5a24-4085-8cb3-08dd7cecea01 X-MS-Exchange-CrossTenant-Id: 02f4eddd-f9a7-41fd-ab0f-050b4ecc86e8 X-MS-Exchange-CrossTenant-AuthSource: AM3PEPF0000A794.eurprd04.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-EndToEndLatency: 00:00:05.2498469 X-MS-Exchange-Processed-By-BccFoldering: 15.20.8632.017 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(930097)(140003); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?9anehW4On9FwJJAT0PkmeZ9YhEbcDqT7EfJHB5pH6ZUZtXCZEperoxA23G73?= =?us-ascii?Q?yhC+mkd5N/R2OOGTCR3Mbb3iYIxFy7D0oV0G5Ca0wpRA+zsnPE2W7GnG2WjH?= =?us-ascii?Q?aafHZbCzCekHfoxnD11ocOQvSiBgITXiY39vzwhOatFfEnpzYB6Y4B/NUVIe?= =?us-ascii?Q?5C7lHOLSUmUSShmmg66pjNiH66mUi6qKfOXSU3fxC3j//IJGjg1kriXvGMlh?= =?us-ascii?Q?Cq6Ryrke6oJ3KGHodmDFnLU+VZjVWRa7rwB66VUdmH4i0gSXuTYORTQ+XoW3?= =?us-ascii?Q?wsAmhu+XbCCWKkh0ImBHjjSkLrMWUDn/CbBwY7eSSiDXKb82RiuYwBvYVvPw?= =?us-ascii?Q?SlFRiqAjdcC/duIF9A/PmLC8WCsL03r9J55tkFj9myUNR8+LuzJLFmIaNv5B?= =?us-ascii?Q?K+EDBDS0zntj21Pf1aaIgoGEn29ezijLmSZzpQ9FJ6Vcod7qkpyMVIYcF01K?= =?us-ascii?Q?c+mTH3gh4UtBoRj7yMxZSunr9Dgf8Djyhd875TC79RKtCCxF/h70fV42fN0g?= =?us-ascii?Q?nf8UXbGs1JcV1w90/T6ShWPF7vVaZIAlnfXKeWoPnA60fw91ZkuN5TSg0pjb?= =?us-ascii?Q?QG1GW2WS5RAIEdGeOfQF24Aq39P0I+5ktDBPhzX4TY51tdS7UTKmVpBlxhq+?= =?us-ascii?Q?tu421gIV0LlgXCuiolTESPeslQ/BeFyUJeOV9ULJbFMdMgDs1vMnn7yiCXm5?= =?us-ascii?Q?ychRuhkzL9hSAO8MPFEivvL53Ou05CU9KYmVm4lX1h/HY1TzDip j+U12WT0F?= =?us-ascii?Q?OJE4OIFxpXIuq1bbLIep8wbg6q7AGOIUV0T0+v7XdXNqPv7k/5AueA2p9SJ8?= =?us-ascii?Q?tThL4Wvpi3MwC1fZZE7edh9VtNVMQHTdJbJPWmKYFcLGwZdFRFqfQ2hK6s6r?= =?us-ascii?Q?ImQHBQWG9Li3xe1wVi5QQla3BYKiNkzFrhQ8CNi95rt1YHQVt1KpDehy4vv5?= =?us-ascii?Q?B3pU//JIc2K0hcdQTsu/niiSZG6wsHF/AxdTD0BfVbudwP54L45GARH/IuNZ?= =?us-ascii?Q?xQPr7oeUTa+t+x88aQASsXFdszy+KXc7IeWrQPNq8iPzK8Gp7PCcrw6hXuKK?= =?us-ascii?Q?xt8iqY0qt1SpDEQ1/I5xiboWxxiPyepasL4FVaD3ZxqbksmTFsCroP9Lq2HR?= =?us-ascii?Q?R8VKjMBYIm2yKZ8neJbz1fuUnlbD33XlQqStF5gmQO13kqNb+d+d3sPoQGKY?= =?us-ascii?Q?lk3VsTv4dDdIjL4Rq28Bwzubq9fIgJlDGcP/g/Zx1QCUTVPwQgAJc74Ihjhl?= =?us-ascii?Q?Bx5YiWPpioXODrX4LR4a6AHNWvl/8+qOk6DDhj2od+4ghEzBidfpzYnbnVy3?= =?us-ascii?Q?d6HhCmG+Z/6HWiPTOhqmbNvyHqrDlZdy5DAGD7/g1Q+pG5gN+s8MesBsnX82?= =?us-ascii?Q?XgSUcWmnDLISykPyTeY+SW1o+PR52NpMkTwpx2SWNXX0faB46nLNhlK+IGVP?= =?us-ascii?Q?/9yPhRP3IqcR5cxWJ073k6eAFNj3/nvH71Xq1L1YZk6JqsTRpMcITpquWFoZ?= =?us-ascii?Q?1OWrabRIh/m9166y7qIiFPS3AoQIaH27/3jUV RPh6W9dr+fDYyOPYTYcNsZa?= =?us-ascii?Q?+wMmZc3b6tI43dKlfvA8eKY408TZ3L51Jpgfz3boAO7+KF3+IXrkG3ixGQ9O?= =?us-ascii?Q?a8bZvp/WO6f/P5WXaPLH0OxT9hi48/6f73S7pZQ1p1ig9CUMxZCnuhmoV/c5?= =?us-ascii?Q?s1OAx/b0OPetv25Bw6Ksk2EDX7aQNMxbEwr875PvB9/fhiEnwfTrYDwlDhJH?= =?us-ascii?Q?ZZp7gw9GurtNfK/5Hoxs0qkQPy2cz+UXkpScIzEbotyo4fV41a5QhY7sEgEv?= =?us-ascii?Q?eqbWjW7+KqWJiF+U4zH49yBWZWUGQQ5bnpicUdWqvzG9m0zxLfj1XAqE4CfW?= =?us-ascii?Q?xHC5fDQxSC9CClsip1+zxlKyBGA1G4fNKFz/Jfd/oaZqm8pQ0uJzJRESH0gm?= =?us-ascii?Q?oDiFazfBX3XFFpgEhc72s9k2X+M2fpcOydrlIU3rQzZxk6GFwwtxDS1o4I6x?= =?us-ascii?Q?qM0+eqU+60YCfYSgLXJ7X5h0b9Fic96vh4gjULL3wu7IX2KEYbBtOjGGz0UA?= =?us-ascii?Q?qEU6nWLa?= Content-Language: en-us received-spf: Pass (protection.outlook.com: domain of geenidoonor.ee designates 2a01:111:f403:260d::72f as permitted sender) receiver=protection.outlook.com; client-ip=2a01:111:f403:260d::72f; helo=EUR03-DBA-obe.outbound.protection.outlook.com; pr=C dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=geenidoonor.ee; s=selector1; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=2mEhkfVS4lZkrISbScDtfu7JEaRNpWL209Ql7iTZvVE=; b=r1Tru54uBm6Ui1SZoQW9qs8uGNVqaGHTwdoU0qaYwg4OIjfxw+v+ezpjZoGuXoFd/rjuJDsrlewOtM2A4m9VX8FCcOin55VkiOVVlDpVesSDtaLT5iYhn6sszRVyKHP7TxSFvYAUgLJig9zVSHCIAT9TeuKO6hFhlnQGe2G8qRckdR84DOBoBo6z8BpiarYL30vrw2KQnXvcJbltS1FM2/1N/UqvGmBdrRE7DedkqdKB99Vzh2uW9wRQNhdoWtJj1jq57puv1xrVtoScCXRD4D34aZvL2nyzbihrRv9mnOPqy+aIvRUwXJcSynGw7dKYc58hK8I9nPNEV2s49OUGog== acceptlanguage: et-EE, en-US x-ms-exchange-messagesentrepresentingtype: 1 x-ms-exchange-usermailbox-routingagent-processed: True X-MS-Exchange-AntiSpam-MessageData-Original-ChunkCount: 1 X-MS-Exchange-AntiSpam-MessageData-Original-0: =?utf-8?B?MVJoSWZyRTF4T0FtMlQ1Tkl3WE1PTldCVU5wcDA0ZzgrU2FmOVp5N20yZ2ls?= =?utf-8?B?bGsvMHdURnBkT1RmRitmV2tOblNJTWQ0REdKOW5VemNDdHpPTjJRcmhDdzNx?= =?utf-8?B?Vy9xWHpBUXN1TUlLcExTcytLV0U0d2FzZG9CSXprRm50V1lNSy9Nb0IzTDJl?= =?utf-8?B?T011RW1yaW1HOWFuRUczbm9rMnNFYTUzMWFsUXNCbkRCMTBNaHRFRFVFMWtt?= =?utf-8?B?U3NlWFVYeng5dGVOcWptR0R6WUZ0S2gyeHRUcm9yZmJnK1JqNjY5NGYvVzlm?= =?utf-8?B?SFpGK1dZSmRlUmJjZGtDR3BVbHlmQWc4aVBOQ2hsZTJ5NldSdFp4YlVScTRJ?= =?utf-8?B?OVdkNUhnYkthZGpKZTNZQ0ZlSFFEQzQ1OTczYXgyT21RekxsWGgwNkN6UTZ3?= =?utf-8?B?cTZ0L2t5Y2p3dkcyYjJwUngyRTVNa1FwREZlNkRiNEpKK2s5N25qUHN5MnU0?= =?utf-8?B?ZW94YndJOHJFOEtnQisyRC83blRCZFUwZEt2aGJnZ2Q1WU8zUFRoQnJrZjNt?= =?utf-8?B?QThjWWR4MW40Zm5iRUc1bzljVnpPUVU4RlpBa3BHVDFNVHpLV2VuMlpiSXBu?= =?utf-8?B?cU82TGl5WXo4bnIxSXM0VHBmUUNCeVJHMzVmSkRxWGlSa0ZBRFdpTVBTUzd3?= =?utf-8?B?MnFzRkhJbjgvdThqd2Q3bmNpSktrTFRyUHpHN0wyQ21hL1NsTmx0aytocitq?= =?utf-8?B?MEVHMk5FVVJpZGVZMGI5L040QUNmKzFyc3ZpM3I2dHZRRktLbVB4V2UvRGh2?= =?utf-8?B?NTdjR1pFYUFWYmh TRVA5Y1p4NFZMN01nQVZiaDJ0NldQRFlFZmVQb24vcU0w?= =?utf-8?B?VlhPSzhnT0g5d3FmRG9UZnZUdmw2dzJYRC9FS2NMa0p3Tm14VXg4czZRTG9K?= =?utf-8?B?cGNWbkZqRTZkSFAxeXJOVEtjN3NWQi81UE5wSDdMUW9Pa3RKQ3pFUis3NHh1?= =?utf-8?B?Rm13aUdGS1J3T3dKcksvY3h5SjJMTzFLaUJacDZRUDJmajhPSDNFQjM3dnZj?= =?utf-8?B?L0I2L0NWQnV6aGUxVWpnbjJtaGxIdVZJUURFb256S1RwVk45THhyamJzemRJ?= =?utf-8?B?aGhQR2EzN09kRDZ2T2Y5WWwzQkp0SnFkbnA0OEVCVzdlcWtpL3VLOStEcm5Z?= =?utf-8?B?TFhYS0pxK3BPRHY3MDNCVDgvV3FOWXJCUTdkVGwzbExRaHNxWGpYUTlPYzZO?= =?utf-8?B?QU12VG5xaXMyWWxUdU5kMHZ0OTU4SlUyWHZRQ3d5VGE2bUhTME9UVzVMcGVa?= =?utf-8?B?S3ZFdW9ZVkdJVHJDanorcURpZFExRDlQYXBzdG4rYTMxQ3hPdlR2SFkyTlNU?= =?utf-8?B?UzZJMGVJc2xZUEpuMjNlS1UxQVp6S3ZXZGtlNi8vUHNTWTI1dGpPU3VrT2kz?= =?utf-8?B?aHZmc0ZFL0pmY3JRNnROdXJWazFVSjRUZ2ZZN3l1b09aSXg4akVVbElJaEJy?= =?utf-8?B?WWZCQk95a05ITWVFQk1IamhVOCs0UlpOWVlMZEJuNXBmMmU2bGtWMVJIbm1o?= =?utf-8?B?YTVsOStHSWlCZlV1bFJ4U3RxL3Z1OVEyQUxrVFNnV1I3YXRmNnc0dC9ON3Fs?= =?utf-8?B?U0tzRHhheDdGL1hXL284MkZIa0wvcmdHWDZkQXE1 ZGgwdWNWYWhQUWsxbmxx?= =?utf-8?B?eGQzd0tJVHQwRlo2QkVxK2FhdFhZQjFsS1hFdStvTzhwU29nM0V6MnhoMmw5?= =?utf-8?B?ZmFpK1hNZW9JQkVFcDE1QVpiK0ZYTm1jS0k1anR2SXRiNnYyekgyejRkTHB2?= =?utf-8?B?WmFCZDA1V1V5ODJneG0va0NIU3VDbHhzNGo1dEJuY0lXQ2FiZWN3OW55Umdt?= =?utf-8?B?SmxIWCtzL3RDb3plT3Fhd2Z2MUJ6YlM4SEV2cEpIVUNGNjVRck5vaWI0cTVM?= =?utf-8?B?dmNQb1RTL0ZZMVVEaXRvbjhVb1BaRDBOS0pTMGE1ejZVQWNSQmU1UldWdHl2?= =?utf-8?B?LzdQY3c3S1NNdUs4RmwzMnJXK0xXakRPQUp5MEk4VklrRjQvNGo2WUUyK2o1?= =?utf-8?B?aUNSS3BBZUR3bkVPZUs1ZVBLMHROZGlEUjB2V3BsWXNzNmt0MHdMSExSNFNl?= =?utf-8?B?eEkyUUxSenV6WVpwMzVMaWVWZDZwMUd3bENPSDhxU1oxOGliQ3Q3aStDUk14?= =?utf-8?B?TEdvS1NCckpxTnVya1Qwd0VNY2Q5c2J4KytwOFJSc09oVW8wZ1c2cWlDWXdC?= =?utf-8?Q?77XLGx9JeQ4PHXQQZdvaoWo=3D?= X-MS-Exchange-Transport-CrossTenantHeadersPromoted: AM3PEPF0000A794.eurprd04.prod.outlook.com This is a multipart message in MIME format. ------=_NextPart_000_0034_01DBCA31.E3D69220 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Lugupeetud dr. Padrik Anname teile teada, et kahjuks on osutunud teie taotluse alusel geeniandmete väljastamise lahenduse väljatöötamine oodatust aeganõudvamaks, ning käesolevaga teavitame teid, et vastavalt isikuandmete kaitse üldmääruse (EL) 2016/679 artikli 12 lõikes 3 toodud korrale pikendame teie taotlusele vastamise tähtaega kuni kahe kuu võrra. See tähtaja pikenemine võtab arvesse taotluse keerukust, sest nagu eelnevas kirjas öeldud, on tegemist esmakordse taotlusega, kus geenidoonor ei soovi andmete väljastamist endale isiklikult, ja seega ei ole geenivaramus sellise andmeväljastuse protsessiks automatiseeritud lahendust ega ka vaba inimressurssi käesoleva taotluse kiiremaks menetlemiseks. Teeme jätkuvalt kõik selleks, et väljastada andmed esimesel võimalusel. Täname mõistva suhtumise eest. Lugupidamisega Eesti geenivaramu From: Peeter Padrik Sent: Tuesday, 18 March 2025 11.59 To: Info Geenidoonor Cc: Lili Milani ; Mait Metspalu Subject: Taotlus geeniandmete väljastamiseks Tere, Saadan siin taotluse geenidoonori volituse alusel tema geenivaramus oleva genotüübi andmete väljastamiseks arstile tervishoiuteenuseks. Tegime päringu vastava teenuse osas ka sotsiaalministeeriumile, kelle hinnangul on selline teenusmudel volitusega igati olemasoleva õigusruumiga kooskõlas. Lugupidamisega, Peeter Padrik, MD, PhD CEO / Oncologist Antegenes Mob: +372 5018533 I Whatsapp: +372 53319800 peeter.padrik@antegenes.com Raatuse 21, Tartu 50603, Estonia www.antegenes.com The content of this email is confidential and intended only for the recipients specified in the message. It is strictly forbidden to share any part of this message with any third party, without the written consent of the sender. If you received this message by mistake, please reply to this message and follow with its deletion, so that we can ensure such a mistake does not occur in the future. ------=_NextPart_000_0034_01DBCA31.E3D69220 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable

 

Lugupeetud dr. Padrik 

 

Anname teile teada, et kahjuks on osutunud teie taotluse = alusel geeniandmete v=C3=A4ljastamise lahenduse = v=C3=A4ljat=C3=B6=C3=B6tamine oodatust aegan=C3=B5udvamaks, ning = k=C3=A4esolevaga teavitame teid, et vastavalt isikuandmete kaitse = =C3=BCldm=C3=A4=C3=A4ruse (EL) 2016/679 artikli 12 l=C3=B5ikes 3 toodud = korrale pikendame teie taotlusele vastamise t=C3=A4htaega kuni kahe kuu = v=C3=B5rra. 

See t=C3=A4htaja pikenemine v=C3=B5tab arvesse taotluse = keerukust, sest nagu eelnevas kirjas =C3=B6eldud, on tegemist esmakordse = taotlusega, kus geenidoonor ei soovi andmete v=C3=A4ljastamist endale = isiklikult, ja seega ei ole geenivaramus sellise andmev=C3=A4ljastuse = protsessiks automatiseeritud lahendust ega ka vaba inimressurssi = k=C3=A4esoleva taotluse kiiremaks menetlemiseks. Teeme j=C3=A4tkuvalt = k=C3=B5ik selleks, et v=C3=A4ljastada andmed esimesel = v=C3=B5imalusel.  

 

T=C3=A4name m=C3=B5istva suhtumise = eest. 

 

Lugupidamisega

Eesti = geenivaramu

 

From: Peeter Padrik = <peeter.padrik@antegenes.com>
Sent: Tuesday, 18 March = 2025 11.59
To: Info Geenidoonor = <info@geenidoonor.ee>
Cc: Lili Milani = <lili.milani@ut.ee>; Mait Metspalu = <mait.metspalu@ut.ee>
Subject: Taotlus geeniandmete = v=C3=A4ljastamiseks

 

Tere,

 

Saadan siin taotluse geenidoonori volituse alusel tema = geenivaramus oleva genot=C3=BC=C3=BCbi andmete v=C3=A4ljastamiseks = arstile tervishoiuteenuseks.

 

Tegime p=C3=A4ringu vastava = teenuse osas ka sotsiaalministeeriumile, kelle hinnangul on selline = teenusmudel volitusega igati olemasoleva =C3=B5igusruumiga = koosk=C3=B5las.

 

Lugupidamisega,

 

 

Peeter Padrik, MD, = PhD

CEO / Oncologist

Antegenes

Mob: +372 5018533 I Whatsapp: +372 = 53319800

peeter.padrik@antegenes.com =

Raatuse = 21, Tartu 50603, Estonia

www.antegenes.com

 

The = content of this email is confidential and intended only for the = recipients specified in the message. It is strictly forbidden to share = any part of this message with any third party, without the written = consent of the sender. If you received this message by mistake, please = reply to this message and follow with its deletion, so that we can = ensure such a mistake does not occur in the future.

 

 

 

 

 

 

 

 

 

------=_NextPart_000_0034_01DBCA31.E3D69220--